|
|
|
LifeScienceHistory.com - Check us out on Instagram
Arizona Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing ArizonaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
SynCardia Systems, Inc.
| | | Phone: | (520) 545-1234 | Fax: | (520) 903-1782 | Year Established: | 2001 | Main Contact: | J. David Mackstaller, VP, Corporate Development | | Other Contacts: | Brian Brogie, VP, Manufacturing & Facilities Dena L. Richter, CFO Mary Pat Sloan, VP, Global Training and Customer Support Carole E. Marcot, VP, Quality & Regulatory Affairs Don Webber, COO Richard G. Smith, MSEE, CCE, Co-Founder & CTO Michael Garippa, President & CEO Marvin J. Slepian, M.D., Co-founder, Chairman, CSO & CMO
| | Company Description | SynCardia Systems is the manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 190 patient years of life on the device.
Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure. The Total Artificial Heart is the only device that provides immediate, safe blood flow of up to 9.5 L/min through both ventricles.
On Sept. 20, 2016 SynCardia Systems has successfully completed its reorganization process and has been acquired by affiliates of investment firm Versa Capital Management. SynCardia will continue to be headquartered in Tucson, Ariz.. | |
|
|
|
|
|